Opportunity to benefit over 2 million patients annually
The X Cor™ platform has the potential for use in multiple minimally invasive procedures, including hysterectomies which are performed over a million times annually.
A $2 billion market potential
With the huge number of procedures performed and the clinical value that Xcor™ may provide, the untapped market of minimally invasive specimen removal can grow to be $2B over the next five years.
2.2M Worldwide Annual Procedures